Dr. Kilaru is a Clinical Associate Professor of Medicine at NYU Grossman School of Medicine, where she also serves as Program Director of the Transplant Hepatology Fellowship. She currently serves as Chair of the AASLD Inclusion and Diversity Committee.

Dr. Lauren Nephew is Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology and the Associate Vice Chair of Health Equity for the Department of Medicine at Indiana University School of Medicine. Her research program focuses on understanding how the structural and social determinants of health contribute to disparities in liver disease and developing interventions that improve access to care. <br><br>Dr.

Pediatric Transplant Hepatologist at UTSW, Dallas, TX

Name: SHIVARAM PRASAD SINGH<br>Current Designation/Institution: Chairman, Kalinga Gastroenterology Foundation, Cuttack.

Dr Anil Arora completed all his academic studies of MBBS,DNB(MED),MD(MED),DM(GASTRO) from prestigious AIIMS. He Subsequently obtained his LIVER TRANSPLATATION fellowship from QUEEN ELIZABETH hospital BIRMINGHAM in 1999 and was awarded FELLOWSHIP of Royal college of physicians of EDNINBURGH, FRCP(EDINBURGH) in 2004 and FELLOWSHIP of Royal college of physicians of London, FRCP(London) in 2014.and FAMS 2023. FAASLD,FSGIEI,FASGEI<br>At present he is the Chairman of Institute of liver gastroenterology and pancreaticobiliary sciences at Sir Ganga Ram Hospital.

Prof. Ajay Duseja is presently working as Professor and Head in the department of Hepatology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. He did his MBBS in 1988, MD (Internal Medicine) in 1992 and DM (Gastroenterology) from PGIMER, Chandigarh in 1996. For last 30 years, he is working as Faculty with focused research in the field of Hepatology.

Calvin Q. Pan, MD, MACP, FAASLD, is a distinguished Professor of Medicine at NYU School of Medicine in New York, USA. He has held significant leadership roles in professional societies, including serving as Chair of Online Learning at the American Association for the Study of Liver Diseases (AASLD), Co-chair of the 2025 AASLD Hepatitis B Practice Guidelines, Co-chair of the 2025 Hepatitis B Guidelines of the World Gastroenterology Organization (WGO), and Chair of the Hepatitis B Special Interest Group<br><br>Dr. Pan's research focuses on viral hepatitis.

Mandana Khalili, MD, MAS is a Professor of Medicine at University of California San Francisco (UCSF) and the Director of Clinical and Translational Research in Hepatology and Chief of Clinical Hepatology at UCSF/San Francisco General Hospital. Her research focuses on addressing epidemiology, systemic complications and outcomes, novel therapies, and health policy related to viral hepatitis, steatotic liver disease (metabolic dysfunction-associated and alcohol related), cirrhosis and liver cancer.

I am a computational biologist by training and currently an Assistant Professor in the Division of Pediatric Gastroenterology, Hepatology and Nutrition at Cincinnati Children's Hospital Medical Center. My primary research objective is to advance our understanding of autoimmune liver disease pathogenesis through the modeling of high-dimensional data, particularly genomics data. I have focused on single-cell genomics and spatial transcriptomics, utilizing both public and in-house profiling data to explore biological processes in health and disease.

Kazumichi Abe, MD, PhD is Associate Professor and Chief of the Gastroenterology Unit in the Department of Gastroenterology at Fukushima Medical University. He graduated from Fukushima Medical University in 1999 and obtained his PhD in 2008. From 2004 to 2007, he trained at the University of California, San Diego in molecular immunology. Dr. Abe's clinical and research interests focus on hepatology, particularly autoimmune liver diseases, chronic hepatitis, and mechanisms of liver injury and resilience.